Harvinder Virk is an NIHR Academic Clinical Lecturer in Respiratory Medicine and MRC New Investigator in the Department of Respiratory Sciences at the University of Leicester. Based at the NIHR Leicester Biomedical Research Centre at Glenfield Hospital, he combines clinical practice with research focused on improving outcomes for people with interstitial lung diseases.
Harv completed his medical degree at the University of Birmingham and a PhD at the University of Leicester investigating molecular mechanisms involved in lung fibrosis. He is a Member of the Royal College of Physicians and previously held an MRC Clinical Research Training Fellowship.
Harv co-founded Only Good Antibodies, an open-science community and data platform working to improve how antibodies are selected, validated and reported. He co-leads the UK arm of the YCharOS consortium, is Deputy Chair of the UK Reproducibility Network Supervisory Board and serves as Leicester Deputy Lead for the MRC-AIM Doctoral Training Partnership.
Harv is a clinician-scientist whose research addresses barriers to the reliable translation of biomedical research into patient benefit. His work combines independent, knockout-controlled characterization of antibodies and other protein-binding reagents with studies of interstitial lung disease, pulmonary fibrosis, biomarkers and treatment selection.
At SGC-Leicester, his group will develop high-throughput, flow-cytometry-based approaches to evaluate the potency and selectivity of emerging protein binders, including AI-designed binders, in relevant cellular contexts. The programme will focus particularly on cell-surface and secreted proteins and will generate openly available characterization data and reference materials to support reproducible research and drug discovery.